Published in Healthcare Mergers, Acquisitions and Ventures Week, April 17th, 2004
"Over the past year we have remained on course for further growth, despite considerable currency upheavals and a very weak dollar. Achieving growth in sales of 5% and a return on sales of over 21% against that kind of background illustrates the operating strength of the Altana Group and makes us one of the most profitable companies of the German economy," commented Nikolaus Schweickart, chairman of the management board at the report on business year 2003.
Altana's sales rose by 5% in 2003 to EUR 2.7 billion (2002: EUR 2.6 billion). Adjusted for exchange rate and acquisition effects,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.